160 related articles for article (PubMed ID: 17508759)
1. Tautomeric modification of GlcNAc-thiazoline.
Knapp S; Abdo M; Ajayi K; Huhn RA; Emge TJ; Kim EJ; Hanover JA
Org Lett; 2007 Jun; 9(12):2321-4. PubMed ID: 17508759
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.
Amorelli B; Yang C; Rempel B; Withers SG; Knapp S
Bioorg Med Chem Lett; 2008 May; 18(9):2944-7. PubMed ID: 18406613
[TBL] [Abstract][Full Text] [Related]
3. OGA inhibition by GlcNAc-selenazoline.
Kim EJ; Love DC; Darout E; Abdo M; Rempel B; Withers SG; Rablen PR; Hanover JA; Knapp S
Bioorg Med Chem; 2010 Oct; 18(19):7058-64. PubMed ID: 20822912
[TBL] [Abstract][Full Text] [Related]
4. GlcNAc-Thiazoline conformations.
Knapp S; Fash D; Abdo M; Emge TJ; Rablen PR
Bioorg Med Chem; 2009 Mar; 17(5):1831-6. PubMed ID: 19223181
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors.
Kong H; Chen W; Liu T; Lu H; Yang Q; Dong Y; Liang X; Jin S; Zhang J
Carbohydr Res; 2016 Jun; 429():54-61. PubMed ID: 27233493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of NAG-thiazoline-derived inhibitors for β-N-acetyl-d-hexosaminidases.
Kong H; Chen W; Lu H; Yang Q; Dong Y; Wang D; Zhang J
Carbohydr Res; 2015 Sep; 413():135-44. PubMed ID: 26142545
[TBL] [Abstract][Full Text] [Related]
7. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate.
Kim EJ; Amorelli B; Abdo M; Thomas CJ; Love DC; Knapp S; Hanover JA
J Am Chem Soc; 2007 Dec; 129(48):14854-5. PubMed ID: 17994748
[TBL] [Abstract][Full Text] [Related]
8. Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.
Li T; Li Z; Li J; Wang J; Guo L; Wang PG; Zhao W
Bioorg Med Chem Lett; 2012 Nov; 22(22):6854-7. PubMed ID: 23058883
[TBL] [Abstract][Full Text] [Related]
9. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.
Stubbs KA; Zhang N; Vocadlo DJ
Org Biomol Chem; 2006 Mar; 4(5):839-45. PubMed ID: 16493467
[TBL] [Abstract][Full Text] [Related]
10. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
[TBL] [Abstract][Full Text] [Related]
11. Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA).
Igual MO; Nunes PSG; da Costa RM; Mantoani SP; Tostes RC; Carvalho I
Carbohydr Res; 2019 Jan; 471():43-55. PubMed ID: 30412832
[TBL] [Abstract][Full Text] [Related]
12. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.
Dorfmueller HC; Borodkin VS; Schimpl M; Shepherd SM; Shpiro NA; van Aalten DM
J Am Chem Soc; 2006 Dec; 128(51):16484-5. PubMed ID: 17177381
[TBL] [Abstract][Full Text] [Related]
13. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases.
Dorfmueller HC; Borodkin VS; Schimpl M; Zheng X; Kime R; Read KD; van Aalten DM
Chem Biol; 2010 Nov; 17(11):1250-5. PubMed ID: 21095575
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase.
Macauley MS; Vocadlo DJ
Carbohydr Res; 2009 Jun; 344(9):1079-84. PubMed ID: 19423084
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
[TBL] [Abstract][Full Text] [Related]
17. Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.
Ho CW; Popat SD; Liu TW; Tsai KC; Ho MJ; Chen WH; Yang AS; Lin CH
ACS Chem Biol; 2010 May; 5(5):489-97. PubMed ID: 20187655
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of human OGA structure in complex with PUGNAc and NAG-thiazoline derivatives.
de Alencar NA; Sousa PR; Silva JR; Lameira J; Alves CN; Martí S; Moliner V
J Chem Inf Model; 2012 Oct; 52(10):2775-83. PubMed ID: 22937904
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, evaluation, and mechanism of N,N,N-trimethyl-D-glucosamine-(1→4)-chitooligosaccharides as selective inhibitors of glycosyl hydrolase family 20 β-N-acetyl-D-hexosaminidases.
Yang Y; Liu T; Yang Y; Wu Q; Yang Q; Yu B
Chembiochem; 2011 Feb; 12(3):457-67. PubMed ID: 21290547
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of O-GlcNAcase inhibitors via 'click chemistry' and biological evaluations.
Li T; Guo L; Zhang Y; Wang J; Li Z; Lin L; Zhang Z; Li L; Lin J; Zhao W; Li J; Wang PG
Carbohydr Res; 2011 Jul; 346(9):1083-92. PubMed ID: 21514574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
